Oric Pharmaceuticals

ORIC

Valor de mercado US$ 1,37 bi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Nextech Invest Zurich, Switzerland	US$ 37,4 mi	–	–	–
2	2 Fidelity Investments Boston, Massachusetts	US$ 34,8 mi	-US$ 933 mil	-104.240	-2%
3	3 BlackRock New York	US$ 34,2 mi	+US$ 14,8 mi	+1.652.695	+52%
4	4 VR Adviser New York	US$ 31,1 mi	–	–	–
5	5 Frazier Life Sciences Management Palo Alto, California	US$ 29,3 mi	–	–	–
6	6 Viking Global Investors Stamford, Connecticut	US$ 28,3 mi	–	–	–
7	7 Alkeon Capital Management New York	US$ 26,9 mi	+US$ 895 mil	+100.000	+3%
8	8 Column Group San Francisco, California	US$ 25 mi	–	–	–
9	9 EcoR1 Capital San Francisco, California	US$ 24,2 mi	–	–	–
10	10 Vanguard Group Malvern, Pennsylvania	US$ 22,6 mi	+US$ 2,84 mi	+317.671	+11%
11	11 State Street Boston, Massachusetts	US$ 16 mi	+US$ 4,84 mi	+540.147	+31%
12	12 Commodore Capital New York	US$ 14,1 mi	–	–	–
13	13 Boxer Capital San Diego, California	US$ 12,2 mi	–	–	–
14	14 First Turn Management Del Mar, California	US$ 10,7 mi	+US$ 3,75 mi	+418.389	+38%
15	15 NEA Management Company Timonium, Maryland	US$ 10,6 mi	–	–	–
16	16 ArrowMark Colorado Holdings Denver, Colorado	US$ 9 mi	-US$ 2,12 mi	-237.339	-16%
17	17 Vivo Capital Palo Alto, California	US$ 8,98 mi	+US$ 3,76 mi	+419.995	+49%
18	18 Geode Capital Management Boston, Massachusetts	US$ 8,65 mi	+US$ 2,78 mi	+311.059	+34%
19	19 T. Rowe Price Associates Baltimore, Maryland	US$ 8,41 mi	-US$ 3,38 mi	-377.509	-24%
20	20 Silverarc Capital Management Boston, Massachusetts	US$ 7,61 mi	-US$ 333 mil	-37.195	-3%
21	21 Invus Financial Advisors New York	US$ 7,12 mi	–	–	–
22	EC 22 Euclidean Capital New York	US$ 7 mi	–	–	–
23	23 Millennium Management New York	US$ 5,53 mi	+US$ 5,24 mi	+585.447	+297%
24	24 Adage Capital Partners Boston, Massachusetts	US$ 5,52 mi	-US$ 2,24 mi	-250.000	-24%
25	25 Franklin Resources San Mateo, California	US$ 5,33 mi	+US$ 28,1 mil	+3.139	+0,4%

Oric Pharmaceuticals ORIC Valor de mercado US$ 1,37 bi

Oric Pharmaceuticals

ORIC

Valor de mercado US$ 1,37 bi